© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Plaque Psoriasis
Six Ways Psoriasis Costs Extend Well Beyond Treatment of One Condition
October 19, 2018
Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.
Plaque Psoriasis
October 18, 2018
Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control Costs
March 29, 2018
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
How telemedicine will change care delivery and costs in 2018
February 01, 2018
Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
Will biosimilars deliver on expectations?
January 06, 2018
This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
New challenges, opportunities in autoimmune disease treatment
August 24, 2017
Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.
Autoimmune drug pipeline: What health execs should watch
May 06, 2017
New drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease-some recently approved and others coming down the pipeline-could have an impact on the industry.
Watch list 2017: Top therapeutic areas
January 03, 2017
Find out about the latest treatment and drug pipeline developments
Integrating pharmacy benefit, medical benefit cuts costs
November 29, 2016
Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.